Comparing the minimum inhibitory and mutant prevention concentrations of selected antibiotics against animal isolates of Pasteurella multocida and Salmonella typhimurium
Open Access
- 10 January 2022
- journal article
- research article
- Published by AOSIS in Onderstepoort Journal of Veterinary Research
- Vol. 89 (1), e1-e7
- https://doi.org/10.4102/ojvr.v89i1.1955
Abstract
The Onderstepoort Journal of Veterinary Research (OJVR), is the official publication of the Onderstepoort Veterinary Institute. It publishes scientific papers reporting original research on diseases and disease vectors of livestock and wildlife with a focus on Africa, but with results of more than local interest.Keywords
This publication has 21 references indexed in Scilit:
- Workshop report: The 2012 Antimicrobial Agents in Veterinary Medicine: exploring the consequences of antimicrobial drug use: a 3‐D approachJournal of Veterinary Pharmacology and Therapeutics, 2014
- Bacterial Resistance Studies Using In Vitro Dynamic Models: the Predictive Power of the Mutant Prevention and Minimum Inhibitory Antibiotic ConcentrationsAntimicrobial Agents and Chemotherapy, 2013
- Mutant-prevention concentration and mechanism of resistance in clinical isolates and enrofloxacin/marbofloxacin-selected mutants of Escherichia coli of canine originJournal of Medical Microbiology, 2011
- New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approachVeterinary Dermatology, 2009
- J07 Antimicrobial breakpoints-an area for clarificationJournal of Veterinary Pharmacology and Therapeutics, 2006
- Principles of Antimicrobial TherapyVeterinary Clinics of North America: Small Animal Practice, 2006
- Mutant prevention concentration: a new tool for choosing treatment in nontuberculous mycobacterial infectionsInternational Journal of Antimicrobial Agents, 2004
- The mutant selection window and antimicrobial resistanceJournal of Antimicrobial Chemotherapy, 2003
- Restricting the Selection of Antibiotic‐Resistant Mutants: A General Strategy Derived from Fluoroquinolone StudiesClinical Infectious Diseases, 2001
- Mutant Prevention Concentrations of Fluoroquinolones for Clinical Isolates of Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2001